Immix Biopharma (IMMX) Current Leases (2024 - 2026)
Immix Biopharma (IMMX) posted Current Leases of $125392.0 for Q1 2026, down 10.01% sequentially from $139339.0 in Q4 2025, and up 84.9% YoY from $67817.0 in Q1 2025.
Immix Biopharma (IMMX) Current Leases (2024 - 2026) Analysis & Trends
Immix Biopharma has reported Current Leases for 3 years, with the latest figure at $125392.0 in Q1 2026.
- Quarterly Current Leases rose 84.9% year-over-year to $125392.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125392.0 (up 84.9% YoY) and the FY2025 annual result came in at $139339.0, up 113.65% from the prior year.
- Current Leases eased to $125392.0 in Q1 2026 per IMMX's latest filing, from $139339.0 in the prior quarter.
- Over five years, Current Leases peaked at $141282.0 in Q3 2025 and troughed at $34284.0 in Q1 2024.
- A 3-year average of $83874.9 and a median of $67817.0 in 2025 frame the typical range for Current Leases.
- The widest YoY moves for Current Leases: up 125.28% in 2025, down 45.72% in 2025.
- Over 3 years, Current Leases stood at $65219.0 in 2024, then surged by 113.65% to $139339.0 in 2025, then fell by 10.01% to $125392.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $125392.0, $139339.0, and $141282.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Immix Biopharma | 784.75 Mn | 784.75 Mn | - | 111,114.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 111,114.00 |
| Mar 31, 2026 | 125,392.00 |
| Dec 31, 2025 | 139,339.00 |
| Sep 30, 2025 | 141,282.00 |
| Jun 30, 2025 | 70,467.00 |
| Mar 31, 2025 | 67,817.00 |
| Dec 31, 2024 | 65,219.00 |
| Sep 30, 2024 | 62,715.00 |
| Jun 30, 2024 | 48,359.00 |
| Mar 31, 2024 | 34,284.00 |